ADBICA

ADBICA
臨床資料
ATC碼	racemate: 未分配;
法律規範狀態
法律規範	加：Schedule II; 德：NpSG; 英：Class B;
識別資訊
	IUPAC命名法 N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indole-3-carboxamide; ;
CAS號	1445583-48-1
PubChem CID	racemate: 72710773;
ChemSpider	racemate: 29342130;
UNII	racemate: Q71G788A6H; S isomer: P0248QCZ04 ;
CompTox Dashboard（英語：CompTox Chemicals Dashboard） (EPA)	racemate: DTXSID801009996 ;
化學資訊
化學式	C20H29N3O2
摩爾質量	343.47 g·mol−1
3D模型（JSmol（英語：JSmol））	racemate: 交互式圖像; S isomer: 交互式圖像;
	SMILES racemate: CCCCCN1C=C(C2=CC=CC=C21)C(=O)NC(C(=O)N)C(C)(C)C; ; S isomer: CCCCCN1C=C(C2=CC=CC=C21)C(=O)N[C@H](C(=O)N)C(C)(C)C;
	InChI racemate: InChI=1S/C20H29N3O2/c1-5-6-9-12-23-13-15(14-10-7-8-11-16(14)23)19(25)22-17(18(21)24)20(2,3)4/h7-8,10-11,13,17H,5-6,9,12H2,1-4H3,(H2,21,24)(H,22,25); Key:IXUYMXAKKYWKRG-UHFFFAOYSA-N;

ADBICA，化學名N-(1-氨甲醯基-2,2-二甲基丙基)-1-戊基吲哚-3-甲醯胺（英語：N-(1-amino-3,3-dimethyl-1-oxo-2-butanyl)-1-pentyl-1H-indole-3-carboxamide，也稱為 ADB-PICA）是一種含氮有機化合物，化學式C
20H
29N
3O
2，屬於3-吲哚甲醯胺衍生物，可作為合成大麻素，2013年在日本發現^[1]，2015年列入《非藥用類麻醉藥品和精神藥品名錄》^[2]。

參考文獻

^ Uchiyama N, Matsuda S, Kawamura M, Kikura-Hanajiri R, Goda Y. Two new-type cannabimimetic quinolinyl carboxylates, QUPIC and QUCHIC, two new cannabimimetic carboxamide derivatives, ADB-FUBINACA and ADBICA, and five synthetic cannabinoids detected with a thiophene derivative α-PVT and an opioid receptor agonist AH-7921 identified in illegal products. Forensic Toxicology. 2013, 31 (2): 223–240. S2CID 1279637. doi:10.1007/s11419-013-0182-9.
^ 关于印发《非药用类麻醉药品和精神药品列管办法》的通知. China Food and Drug Administration. 27 September 2015 [1 October 2015]. （原始內容存檔於1 October 2015）（中文）.

[1] Uchiyama N, Matsuda S, Kawamura M, Kikura-Hanajiri R, Goda Y. Two new-type cannabimimetic quinolinyl carboxylates, QUPIC and QUCHIC, two new cannabimimetic carboxamide derivatives, ADB-FUBINACA and ADBICA, and five synthetic cannabinoids detected with a thiophene derivative α-PVT and an opioid receptor agonist AH-7921 identified in illegal products. Forensic Toxicology. 2013, 31 (2): 223–240. S2CID 1279637. doi:10.1007/s11419-013-0182-9.

[2] 关于印发《非药用类麻醉药品和精神药品列管办法》的通知. China Food and Drug Administration. 27 September 2015 [1 October 2015]. （原始內容存檔於1 October 2015）（中文）.

[1]

[2]